Condition
Meningioma, Malignant clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Meningioma, Malignant clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Italy (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
This study is testing a new way of giving radiation therapy over five days to see if it helps people with certain types of brain tumors feel better and have a better quality of life after treatment.
-
Using Regorafenib to treat recurrent grade 2 and 3 meningiomas
This study is testing if the medication Regorafenib can help people with recurring grade II or III meningiomas by slowing down tumor growth and improving their health.
Related topics
Quick answers
How many Meningioma, Malignant clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.